Inventurus Knowledge Solutions / Q4-FY26

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-04-??Back to INVENTURUSKNOWLEDGESOLUT

Revenue

₹857 Cr

verified against source

Revenue YoY

18.5%

reported change

EBITDA

₹300 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q4 FY26: 206 · Positive source sentiment · 2026-04-??Q4 FY26206206
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Inventurus Knowledge Solutions delivered a strong Q4 FY26 with revenue of ₹857 crore (+18.5% YoY), EBITDA of ₹300 crore (35% margin), and PAT of ₹206 crore (+39% YoY). Growth was driven by platform adoption, AI-led automation (Scribble Select, MyCare Hub), and strategic acquisitions (TrueBridge, ARI). Headcount grew only 5.3% vs 13% constant-currency revenue growth, demonstrating operating leverage. Management outlined a true north target of tripling EBITDA to ₹3,000 crore by FY30, underpinned by the TrueBridge acquisition and proprietary AI/neurosymbolic models. Key risks include integration complexity of TrueBridge, potential pricing deflation in point-solution features, and elevated leverage post-acquisition.

Colored figures show movement against the previous available record.

Guidance to track

  • Management targets tripling EBITDA from ~₹1,000 crore (LTM Dec 2025) to ₹3,000 crore by FY30, driven by TrueBridge integration and AI-led automation.
  • CFO guided ETR of about 22% for FY27 for the standalone IKS business.
  • Awaiting regulatory approvals; expect to close in coming months. Integration will involve migrating from Cobalt to PostgreSQL and cross-selling RCM and other platform features.
  • Management aims to increase autonomy in each of the 16 platform features using neurosymbolic AI, with Scribble Select and MyCare Hub as recent examples.

Risks flagged

  • The Cobalt-to-PostgreSQL migration and cross-selling system-of-action features into the EHR install base is a 18-24 month process with execution risk.
  • Management acknowledged pricing deflation in easily autonomizable features like ambient AI scribing, which could pressure revenue per customer.
  • The debt-funded acquisition will increase leverage to ~3x EBITDA, requiring disciplined deleveraging and limiting further M&A capacity.
  • CFO noted Q1 calendar is seasonally weakest due to insurance resets and winter, which could impact near-term revenue growth.

Key quotes

  • We have been cutting down the tail of small clients that we had inherited through Acuity... we feel like we'll eventually end up with some number between 500 and 600.
  • Our pricing model has always been outcome based and a percentage of the customer's revenue is how we get paid.
  • The winner over a period of time is going to be a platform system of action versus point solution system of action.

Research modules

Go one layer deeper.